What’s in a Name? Rural Referral Centers Capture 340B Discounts Without Serving Rural, Vulnerable Patients
The 340B Drug Pricing Program is intended to help low-income and vulnerable patient populations and the true safety-net providers that […]
Two-Thirds of 340B DSH Hospitals Are Not Located in Medically Underserved Areas
Analysis Raises Questions on How 340B DSH Hospitals Are Providing Care to Underserved Communities if They Are Not Located in
New Report: 340B DSH Hospitals, Their Child Sites and Contract Pharmacies Failing to Address Health Inequities in Underserved Areas
The Alliance for Integrity and Reform of 340B (AIR340B) released a new report by Xcenda, titled “340B and Health Equity: A Missed Opportunity in Medically
IQVIA: The 340B Drug Pricing Program Exceeds $100B in 2022
This article is the latest in IQVIA’s series of yearly reports on the size and growth of the 340B drug
The New York Times: How a Hospital Chain Used a Poor Neighborhood to Turn Huge Profits
Bon Secours Mercy Health, a major nonprofit health system, used the poverty of Richmond Community Hospital’s patients to tap into
The Wall Street Journal: Many Hospitals Get Big Drug Discounts. That Doesn’t Mean Markdowns for Patients.
A decades-old federal program that offered big drug discounts to a small number of hospitals to help low-income patients now
30 Years of 340B: Policymakers Must Act Now to Prioritize Transparency, Accountability, and Oversight
With the 340B program marking its 30th anniversary in November, we must ask: who is benefiting from this drug pricing
AIR340B to FTC: Outsized role of PBMs in safety-net program harms vulnerable patients
For vulnerable patients across America, getting the 340B Drug Pricing Program right could be the difference between receiving lifesaving care
340B hospital charity care levels still abysmal despite growth in safety-net program
With the unparalleled effects of the COVID-19 pandemic, it makes sense that health care is a top concern for Americans.
New Report Exposes Extreme Profit Retained from 340B Program by Covered Entities, Particularly for Oncology Medicines
Today, the Alliance for Integrity and Reform of 340B (AIR340B) released a new report by Health Capital Group that uncovered